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Background: The HIV/AIDS epidemic continues to disproportionately affect African American communities in the
US, particularly those located in urban areas. Despite the fact that HIV is often transmitted from one sexual partner
to another, most HIV prevention interventions have focused only on individuals, rather than couples. This five-year
study investigates community-based implementation, effectiveness, and sustainability of ‘Eban II,’ an evidence-based
risk reduction intervention for African-American heterosexual, serodiscordant couples.
Methods/design: This hybrid implementation/effectiveness implementation study is guided by organizational
change theory as conceptualized in the Texas Christian University Program Change Model (PCM), a model of
phased organizational change from exposure to adoption, implementation, and sustainability. The primary
implementation aims are to assist 10 community-based organizations (CBOs) to implement and sustain Eban II;
specifically, to partner with CBOs to expose providers to the intervention; facilitate its adoption, implementation and
sustainment; and to evaluate processes and determinants of implementation, effectiveness, fidelity, and sustainment.
The primary effectiveness aim is to evaluate the effect of Eban II on participant (n = 200 couples) outcomes, specifically
incidents of protected sex and proportion of condom use. We will also determine the cost-effectiveness of
implementation, as measured by implementation costs and potential cost savings. A mixed methods evaluation
will examine implementation at the agency level; staff members from the CBOs will complete baseline measures of
organizational context and climate, while key stakeholders will be interviewed periodically throughout implementation.
Effectiveness of Eban II will be assessed using a randomized delayed enrollment (waitlist) control design to evaluate
the impact of treatment on outcomes at posttest and three-month follow-up. Multi-level hierarchical modeling with
a multi-level nested structure will be used to evaluate the effects of agency- and couples-level characteristics on
couples-level outcomes (e.g., condom use).
Discussion: This study will produce important information regarding the value of the Eban II program and a
theory-guided implementation process and tools designed for use in implementing Eban II and other evidence-based
programs in demographically diverse, resource-constrained treatment settings.
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The HIV/AIDS epidemic continues to disproportionately
affect African American communities in the US, particu-
larly those located in urban areas [1,2]. Of all racial/eth-
nic groups in the United States, African Americans have
experienced the greatest burden due to HIV/AIDS, ac-
counting for greatest proportion of HIV infections at all
stages of the disease. HIV/AIDS remains a health dispar-
ity, with Africans Americans representing 44% of all new
HIV infections among adults and adolescents (aged 13 years
or older) in 2010, while only representing 12% to 14% of
the population. In addition, some of the highest rates of
sexually transmitted infections (STIs) are found among
African Americans, further heightening risk for HIV
transmission [3-5].
There is growing evidence that HIV prevention among
African American populations is best accomplished within
the context of risk for transmission among couples because
relationship dynamics and cultural beliefs sometimes
contradict HIV prevention messages [6,7]. Research has
documented low rates of condom use among some Afri-
can Americans with steady partners [8], among African
American HIV-positive women [9-11], and among the
HIV-negative partners of HIV-positive African American
women [11,12]. Among heterosexual relationships, African
American women’s decisions to negotiate condom use are
often influenced by their desire for a partner and a long-
term relationship [13]. Risks for HIV infection can be
heightened when either partner does not accurately per-
ceive their risks for infection, when concurrent partners
exist outside of the primary relationship, or when one
partner is unable to negotiate gender and power dynamics
in a relationship [14]. Therefore, HIV prevention interven-
tions need to target sexual behavior change in the context
of the relationships where risk for transmission occurs.
Recognizing the importance of relationship dynamics,
a small number of couples-based interventions have been
developed and found to be efficacious in reducing risky
sexual behaviors, increasing condom use, reducing STI/
HIV transmission, and sustaining these outcomes [15,16].
However, these interventions have not focused specifically
on heterosexual African Americans and their dispropor-
tionate HIV risks. The National Institute of Mental Health
(NIMH)-funded Eban risk reduction intervention was
designed to fill that gap. Guided by both social cognitive
and culturally-grounded theories [17-20], the Eban
intervention is delivered by trained male–female dyads
in individual, couple-specific, and group sessions. A
cluster randomized trial tested the efficacy of Eban with
535 couples in four U.S. cities [21]. Participants in the
intervention condition reported significantly reduced
rates of unprotected sex and increased rates of condom
use at post-test, six- and 12-month follow-ups, com-
pared to the control condition [21]. These findingsoffered a strong foundation for subsequent clinical effect-
iveness and implementation studies to generate additional
evidence regarding Eban intervention effectiveness in rou-
tine practice settings, and to design and evaluate imple-
mentation strategies intended to facilitate adoption of the
Eban intervention by community agencies and other ap-
propriate service delivery organizations.
The sequence of research activities described above is
suggested by prevailing frameworks guiding the design of
integrated programs of clinical and health promotion re-
search, suggesting a sequence of studies to develop an in-
novative clinical program, test and refine the program
through clinical efficacy and effectiveness studies, and
then facilitate its implementation, sustainment and spread.
These frameworks note that clinical efficacy and effective-
ness studies should be followed by pre-implementation
research to assess barriers and facilitators to program
adoption, followed by pilot implementation studies and
larger trials to evaluate multi-component programs to
facilitate routine program adoption in diverse settings
[22,23]. Thus, achieving the long-term goal of facilitating
large-scale implementation of Eban in agencies that serve
HIV-positive and at-risk African Americans requires a
solid foundation of effectiveness evidence, insights into
barriers and facilitators to adoption and implementation
of Eban with high fidelity, and evidence of the effective-
ness of specific strategies to facilitate adoption.
Although traditional ‘phased’ or ‘pipeline’ models of
clinical research suggest a sequence of separate re-
search activities (clinical efficacy, clinical effectiveness,
pre-implementation, implementation, scale-up/spread),
researchers are increasingly recognizing the need to
combine phases to reduce the time and resources re-
quired to develop innovative clinical programs, estab-
lish their effectiveness, and facilitate their widespread
adoption and benefit [24]. Recognizing the considerable
time delays involved in completing each distinct phase
in this sequence of research activities, Curran et al. [25]
described hybrid effectiveness-implementation study
designs that combine multiple research activities into a
single study to expedite progress across the research
pipeline. With its hybrid design, this project will offer
guidance to future researchers interested in moving
rapidly but thoughtfully from efficacy and effectiveness
research into implementation research, particularly in
resource-constrained settings where implementation
barriers may differ from those seen in efficacy studies.
Specific Aims are as follows:
Primary implementation aims
Aim one
To assist 10 community-based organizations (CBOs) in
implementing and sustaining an evidence-based interven-
tion for HIV serodiscordant African American couples;
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the intervention through training, facilitate its adoption
and implementation, and sustain practice.
Aim two
To evaluate processes and determinants of Eban imple-
mentation and Eban clinical effectiveness to strengthen
the clinical intervention and its implementation by:
1. Assessing acceptability of the intervention, and
barriers and facilitators to its implementation;
2. Examining key determinants of fidelity;
3. Understanding how the project’s implementation
strategies and tools affect adoption, fidelity, and
effectiveness; and
4. Examining key determinants of sustainability.
Primary effectiveness aim
Aim three
To evaluate the effect of intervention implementation
on participant outcomes, specifically incidents of pro-
tected sex and proportion of condom use.
Secondary aim
To determine the cost-effectiveness of implementation
of Eban II, as measured by implementation costs and
potential cost savings associated with a couples-based
intervention.
The study incorporates several innovative features.
First, planning, governance, and specific implementation
activities will be conducted in full partnership between
the research team and community stakeholders, to facili-
tate sustainability following completion of the grant-
funded project. The implementation process will involve
the State of California Implementation Network (SCIN),
a reciprocal, multidirectional information and technol-
ogy exchange between the research team and the collab-
orating CBOs, an approach designed to foster effective
agency adoption [26]. Second, implementation of Eban
II in multiple geographically, culturally, and functionally
disparate agencies requires grounding in organizational
change theory because participating agencies are being
asked to embrace a new evidence-based, couples-
focused intervention approach. Like individual behavior
change, organizational change is notoriously difficult
[27]. Historically, interventions introduced into clinical
settings with little attention to the context have generally
met with resistance and limited success. Greater atten-
tion is now being paid to strategies for supporting
organizational change, particularly by focusing on identi-
fying barriers and facilitators to implementation and
using this information to refine implementation strat-
egies [28,29]. For example, organizational ‘readiness for
change’ [30], as well as staff expectations, perceptions oftheir workload, and attitudes toward evidence-based
practices may encourage or inhibit adoption of these
practices [31], and thus are critical to investigate and ad-
dress [32]. In this study, it will also be critical to examine
the broader context in which the participating agencies
are situated, as the pressures that these agencies face
may well impact their unique and collective capacity to
deliver and sustain evidence-based practices. Third, this
implementation study is organized conceptually around
the Texas Christian University (TCU) Program Change
Model (PCM) [33], which was developed to guide the
process of transferring research into practice [34]. The
PCM involves four action phases: training, adoption, im-
plementation, and practice improvement. Fourth, the
project incorporates a nine-month sustainability period
in which time research team involvement in site-level
activities will be limited to ‘arms-length’ evaluation,
without any intervention or implementation-related ac-
tivities. As recently noted in a systematic review, very lit-
tle research has examined the extent, nature, or impact
of adaptations to interventions that have been imple-
mented [35]. This project will serve to fill a gap in our
knowledge about sustainability as it unfolds prospect-
ively. Finally, this project is unique in its incorporation
of a cost-effectiveness analysis during the course of im-
plementation. This analysis stands to contribute substan-
tially to the ways in which costs affect and are impacted
by community-based implementation of evidence-based
practices.
Methods/design
Overview of study design
Using an effectiveness/implementation hybrid type II re-
search design [25], this study will investigate factors as-
sociated with successful implementation of Eban in a
sample of routine service delivery settings, and real-
world clinical effectiveness of the intervention as it is de-
livered to 180 couples in these settings.
To achieve our two implementation evaluation aims
(aims one and two), a mixed methods evaluation will be
conducted throughout each phase of the TCU Program
Change Model. To achieve our intervention effectiveness
aim (aim three), we will randomly assign couples in a 2:1
design to Eban II (intervention) or to a waitlist compari-
son condition in each of the participating CBOs. This
design allows us to compare the relative effectiveness of
the intervention with couples that receive the interven-
tion immediately vs. those who are waitlisted.
We operationalize ‘successful implementation’ [36] as
a combination of number of couples served (minimum
of 18 couples per agency), three completed cycles of the
intervention, delivery of the intervention with high fidel-
ity, and high level of satisfaction with the intervention.
As noted above, we will also be studying sustainability
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Staff and organizational characteristics will be assessed
at all participating CBOs in the first year, and engage-
ment and training will be priorities. Following successful
training, implementation of Eban II will commence in
two randomly selected CBOs in the first year. The
remaining eight CBOs will be phased in randomly with
refresher trainings in years two through five. At first
glance, it might seem optimal to start all participating
agencies at the same ‘baseline,’ but the structure of the
funding mechanism makes such a design prohibitive due
to the costs associated with implementation in each
agency. By limiting training to two to three CBOs per
year, we will be able to devote sufficient effort to test
whether our implementation approach does in fact
contribute to high fidelity implementation. Also, this
randomized ‘roll-out’ implementation, or dynamic wait-
listed design, has very good statistical properties, includ-
ing higher power than traditional wait-listed designs [37]
and less vulnerability to external, uncontrolled factors
[38]. After each of the collaborating agencies completes
three eight-week intervention cycles, sustainability will
be studied for nine months, during which time only
technical assistance will be provided, as discussed fur-
ther below.
Participating agencies and staff
HIV infection rates in California rank third in the U.S.;
Los Angeles and Alameda Counties have the largest con-
centrations of African Americans in California and, ac-
cordingly, the highest proportion of African American
HIV/AIDS cases [39]. A recent report indicates that the
City of Oakland (Alameda County) has the highest and
most rapidly growing incidence rate of diagnosed and
undiagnosed HIV in the country and is struggling with
what has been referred to in the news as an ‘unstoppable
epidemic’ [40]. The State of California and local stake-
holders have responded to this challenge with active pre-
vention programs such as Get Screened Oakland [41,42].
We recruited ten HIV/AIDS CBOs in Los Angeles and
Alameda Counties to serve as study sites. All of these
agencies are well-established CBOs that serve large
numbers of HIV-infected African Americans. In fact,
these CBOs expressed particular interest in offering ser-
vices to couples because they currently do not provide
such services. These agencies were identified as having
met seven key elements identified in the literature as im-
portant in determining agencies’ readiness to implement
a new intervention [43]. These include: a respected local
community advocate; strong administrative support; for-
mal organizational commitments and stability; commit-
ment of necessary resources to incorporate the program
into existing services; program credibility within the
community; adequate facilitators/staff; and potential forthe program to be self-sustaining or willing to seek add-
itional funding. In addition, all of the agencies have ad-
equate space for conducting private assessment and
group sessions.
Approximately 200 staff members from these agencies
(~20 per agency) will complete the staff- and
organizational-level measures described below. A subset
of these individuals (approximately 50 ‘key stakeholders,’
including agency administrators, site coordinators, and
facilitators) who are directly involved in implementation
will complete semi-structured interviews.
In addition, in order to support potential scale up and
spread of the intervention, each of the agencies will be
asked later in the project to identify two to three add-
itional agencies that may be interested in learning about
Eban II. In the last six months of the study, the Manage-
ment Team will meet at a retreat with the key stake-
holders and representatives from the agencies that they
have identified. Preliminary findings will be discussed,
and participating agencies will describe their experiences
and engage in dialogue about implementation of Eban II.Couples-level sample
The study employs multiple community outreach and
marketing strategies to recruit and screen 215 to 230
couples, expecting to enroll 180 African American het-
erosexual couples. The dropout rate in the Eban ran-
domized controlled trial (RCT) was low at 13% in the
intervention condition [44]. We conservatively project a
17% to 22% overall attrition rate since this study will be
conducted in CBOs rather than in university-based study
sites. Eligibility criteria are as follows:
1. Self-identified heterosexuals
2. One partner is HIV-negative, the other is
HIV-positive, and partners know each other’s
HIV status; serostatus confirmed through written
verification from testing facility.
3. At least one partner identifies as African American.
4. Each partner is no younger than 18 and no older
than 60.
5. Couple has been in a relationship for at least six
months and intends to remain together.
6. Couple reports having unprotected intercourse at
least once in the previous 90 days.
7. Couple has no plans to relocate beyond a reasonable
distance from the study site.
8. Members of couple are willing to complete the study
even if their relationship ends.Activities and procedures
Our implementation approach for Eban II is phased to
correspond conceptually to the PCM and involves
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in the participating CBOs (see Table 1).
With these strategies and tools, our goal is to ensure
that the intervention and its implementation become
sustainable beyond the life of the project, and that par-
ticipating agencies will be motivated to share their expe-
riences with other agencies that may be interested in
serving HIV-serodiscordant couples, i.e., in spreading
the intervention across service agencies.Phase one: training and pre-implementation (year one)
Three main activities occur in year one: a project kick-off,
training, and baseline (developmental) evaluation of staff
and organizational factors. As a key strategy supporting
implementation, we will hold an official ‘kick-off,’ i.e., a
weeklong orientation and training of the program man-
agers, site coordinators, facilitators, agency administrators
and staff, and the data collectors. Consistent with the pro-
cedures used in the Eban RCT, all facilitators will receive
40 hours of training from certified Eban facilitators. All
must demonstrate competency before they are certified as
facilitators. In addition, each year, CBO directors and two
staff members/agency will have the opportunity to be
retrained in order to have fresh skills for the active inter-
vention phase and to maximize their potential for sustain-
ability. Site coordinators and data collectors will receive
10 hours of training and observed practice in their re-
spective region.Phases two and three: adoption and implementation
(years one to five)
These phases involve: developmental evaluation, delivery
of the Eban II intervention, couples-level data collection
(aim three), implementation-focused evaluation, progress-
focused evaluation, and assessment of costs.Table 1 Implementation strategies and tools by Program Cha
PCM Phase Tools and strategies
Training Eban training manuals
Eban videos
Eban Sharepoint
Adoption HIV Fact Sheets (patient and provider version
Adoption Project kick-off
Site coordinators
Implementation Monthly inter-agency calls
Continual feedback on implementation
Technical assistance, especially during sustain
Pre-sustainability workshops
Practice improvement Project wrap-up retreatDevelopmental evaluation
Key stakeholders at each CBO will complete pre-
implementation interviews regarding motivation, inter-
est, receptivity, expectations, capacity to conduct the
project, and existing treatment protocols. Following de-
livery of each cycle of the intervention, stakeholders will
be re-interviewed to inquire about feasibility and bar-
riers. Data from these interviews will be used by the re-
search team to tailor the implementation approach.
Delivery of the Eban II intervention
Agencies will be activated sequentially as cohorts are
completed. The flow of agency participation will be as
follows: year one, two agencies; year two, two agencies;
year three, three agencies; year four, three agencies. All
agencies will be required to complete three Eban cycles
(eight weeks/cycle). In year five, three-month follow-up
evaluation data collection will continue and sustainabil-
ity will be studied at the agencies that complete the ac-
tive phase in year four.
Screening and enrollment of couples
Initial phone or in-person contact with project staff will
be made by the HIV-positive partners who will be
screened to determine their eligibility. If eligible, they
will inform their partner who will contact the staff and
be screened to confirm their eligibility. Consented cou-
ples will be scheduled for the baseline assessment. Socio-
demographic information on couples who do not meet
criteria or refuse to participate and reasons for non-
eligibility or refusal will be collected to permit compari-
sons between eligible participants and non-participants.
The assessment battery will be repeated at the posttest
and three-month follow-up. If couples break up or a
partner is incarcerated or dies, the remaining individual
will be followed throughout the three-month follow-up.
These individuals will receive a ‘break up’ curriculumnge Model (PCM) phase
Purpose
Provides instructions for intervention delivery
Operationalizes intervention core elements
Provides all training tools in accessible format
s) Educates about HIV prevention
Engages sites in project, concretizes expectations
Serve as intervention champions and liaisons
Build sense of communal effort; sustain leadership support
Supports tailoring of implementation strategies
ability Promotes collaboration and commitment to sustainability
Increase likelihood of sustainability
Promotes scale up and spread
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their adherence to safer sex behaviors with new partners.
Couples will be randomly assigned in a 2:1 ratio to either
Eban II active treatment or to waitlist control (WL), with
2/3 (n = 118) of the couples assigned to Eban II and 1/3
(n = 62) assigned to WL in a cross-over design for group
comparisons. At the end of the three-month follow-up,
couples assigned to WL will be offered the intervention
and their three-month data will serve as their baseline for
the treatment analyses. During their time on the waitlist,
couples will be called weekly by the site coordinators to
ensure that they are receiving standard care.
The Eban II intervention
This eight-week, standardized, manualized intervention
is facilitated by a male–female team. The intervention
(see Table 2) involves: strategies that address the broad
array of factors influencing risk behavior among HIV-
affected couples; dyadic and group processes that take
advantage of relationship and group dynamics; and edu-
cational and culturally appropriate sessions [45].
Unlike a traditional RCT, individuals in this study will
not be incentivized for attending sessions. However, our
experience indicates that incentives enhance attendance
and active participation; community agencies frequently
provide such incentives to enhance participation in rou-
tine programs. Therefore, we will provide minimal partici-
pation incentives similar to those often provided routinely
by the agencies, such as bus tokens and gift cards at pre-,
post-, and three-month follow-up. In addition, usual care,
services, and referrals will be available to the WL couples
while they wait to enter the risk reduction program. We
will learn more about the impact of incentives during sus-
tainability, when these incentives are no longer provided.Table 2 Core elements of the Eban II intervention
Sessions Core eleme
Sessions
1. ‘Preparing for the Journey’ (Group Session) Gender, Ethn




3. ‘Tools for the Journey’ (Couple session) Condom Use
4. ‘Sharing the Load’ (Couple session) Gender, Ethn
5. ‘It Takes a Village’ (Group session) Reframing D
6. ‘Strengthening the Village’ (Group session) Self Talk and
7. ‘Expanding the Village’ (Group session) Networking
8. ‘Celebrating our Relationship’ (Couple session) A review of NCouples-level data collection procedures
The self-report assessment developed for Eban and pre-
programmed into Audio Computer-Assisted Self-Interview
(ACASI) [46] takes about 90 minutes to complete. ACASI
provides both audio and video presentation of the ques-
tions and response options on a laptop computer. ACASI
has been shown to significantly decrease social desirability
bias [21].
Implementation-focused evaluation
Several types of assessments will be used to track implemen-
tation processes, specifically with regard to fidelity, dose,
and intensity of intervention. Throughout the intervention,
we will monitor: session attendance, session completion,
and participant satisfaction with sessions. Facilitators will
also complete short surveys noting adherence to the cur-
riculum, level of participation, specific obstacles that may
have arisen, and what components appeared to be most/
least appropriate for the session’s participants. Facilitators
will also complete overall ratings of each couple’s engage-
ment, competency, and knowledge. To assess fidelity, ses-
sions will be digitally recorded. For the first intervention
cohort at each site, all recordings will be reviewed and
feedback will be provided to facilitators. Subsequently, a
random 15% sample of all session recordings will be
reviewed and scored for fidelity to core elements, with a
criterion of 80% or more of the total elements considered
acceptable [47].
Progress-focused evaluation
At the organizational level, this component will involve
assessing the monthly SCIN conference calls. Minutes of
all calls will be maintained (including attendance ros-
ters), as will minutes from all project-related meetings.
Regarding progress at the couples-level, this componentnts
Principles
ic, and Cultural Pride
Listen Technique
isky Behavior
blem Solve with ‘FENCE’
exual Abuse
ic, and Cultural Pride as Couples
ifficult Situations
Relapse Prevention
with others and sexual communication with partners
guzo Saba principles of unity and rededication to protecting each other
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managers and the site coordinators. A periodic onsite re-
view of procedures at each site will be conducted, and a
random selection of 5% of pre- and post-test and follow-
up interviews for each site coordinator and data collector
will be reviewed to ensure that the protocol is adminis-
tered in a standardized fashion.
Cost assessment
The cost of the delivered services will be calculated
using a customized cost-analysis spreadsheet which uses
state of the art recommendations for cost analysis as ar-
ticulated by the US Panel on Cost-Effectiveness in
Health and Medicine [48]. The cost analysis data will be
collected by the data collectors and sent on a quarterly
basis to the management team, and reviewed with the
cost consultant in quarterly conference calls to analyze
the cost information, identify trends, and solve any prob-
lems with data collection.
Phase four: practice improvement
Phase four involves interpretive evaluation, assessment
of sustainability, and a project retreat. Because this pro-
ject will occur in waves, practice improvement will be
examined after each agency completes the active inter-
vention phase (delivery of the groups and completion of
three-month follow-up). Sustainability will be examined
for nine months following the completion of the re-
quired three groups and follow-ups.
Interpretive evaluation
Key stakeholders will have completed interviews regarding
their satisfaction with Eban II during active implementa-
tion, and their expectations regarding sustainability and
cost effectiveness. Following sustainability, these stake-
holders will be re-interviewed.
Sustainability
We define the sustainability phase as beginning after the
active implementation phase is completed at each site
(i.e., baseline through the 3-month follow-up). At this
point, the reliance on grant funds ends and sites will be
encouraged to integrate Eban II into their usual services.
At each site, the nine-month sustainability period will be
preceded by a pre-sustainability workshop to identify
and address any issues that the agencies perceive to be
barriers [49]. During sustainability, Eban II will be deliv-
ered in the CBOs with trained staff serving as co-
facilitators, supported by technical assistance (including
quality assurance) from the management team. Tech-
nical assistance will include retraining in the interven-
tion, sharing resources, offering suggestions on lessons
learned, and review of session tapes to assess fidelity.
Agencies that discontinue participation during this phasewill be contacted to encourage participation and/or to
identify the reasons for discontinuation. Agencies that
independently deliver two eight-week cycles of the inter-
vention with two to three couples in each cycle and
maintain fidelity to the intervention core elements will
be considered to have achieved sustainability. Pre-post
couples-level measures will also be collected in order to
examine outcomes. Sustainability will be assessed by
documenting the number of couples that each agency
recruited and enrolled in Eban II; the number of couples
who completed the intervention; and how much tech-
nical assistance they needed and received.
Project retreat
Additional funds will be sought to support a project re-
treat for the management and implementation teams to
come together with additional representatives from the
SCIN to discuss preliminary findings and the future of the
intervention. Individuals from interested agencies that
were not part of the original 10 CBOs will be invited to at-
tend a designated portion of this retreat, and a structured
discussion guide will be used to explore likelihood of
adoption, perceived need for the intervention, preliminary
perceptions of the program, and its trialability.
Measures to be completed by staff
An electronic Staff Survey will capture basic demograph-
ics of staff (~20 per agency) including education level and
professional experience. The 50-item Evidence-Based
Practices Attitudes Scale (EBPAS) [50] will be used to as-
sess staff attitudes toward evidence-based practices. The
widely used Maslach Burnout Inventory (MBI; Maslach)
[51] will be used to assess staff experience of workload.
Subscales from the TCU Survey of Organizational Func-
tioning (TCU SOF) [52] will be used to assess motiv-
ational factors, program resources, staff attributes, and
organizational readiness. All subscales of the SOF have
demonstrated good internal consistency and validity [53].
In addition to these structured measures, semi-
structured interviews will be conducted with a subset of
key stakeholders (approximate n = 50; five per agency).
Process-focused interviews will include questions about
feasibility, satisfaction, perceived fidelity, barriers, desired
revisions, perceived cost-effectiveness, and expectations
for sustainability. Sustainability-focused interviews will in-
clude similar questions, but will refer to the sustainability
period and their satisfaction with and future expectations
of the utility and cost-effectiveness of Eban II as a long-
term option for agencies’ usual menu of services.
Cost analysis measures
We will use a cost-analysis spreadsheet approach to
measure the cost of HIV prevention, case management,
and adherence services for CBOs providing front-line
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principles, calculates the cost per client of HIV/AIDS
services delivered, and also conducts threshold analyses
to set performance standards for how many HIV infec-
tions would have to be averted for Eban II to be consid-
ered cost-saving or cost-effective to society.
Measures to be completed by clients
Primary behavioral and physiologic outcomes are as
follows:
1. Percentage of condom-protected sexual acts in the
past 90 days.
2. Number of episodes of unprotected sexual
intercourse.
3. Number of sexual partners.
4. Types of partners (primary, casual, new).
5. Frequency of oral, anal, and vaginal sex.
6. Use of alcohol and other drugs prior to sexual
intercourse.
7. Partners’ risk status (e.g., sexual partner has other
partners).
We will also track concurrency, seroconversion, and
incident STIs. In order to control for response bias, sev-
eral steps will be taken, including: assessing sexual be-
haviors over a relatively brief period (i.e., past three
months at baseline and follow-ups and past seven weeks
at post-intervention); providing participants with a cal-
endar for benchmarking salient dates; involving only
trained data collectors in the data collection; using the
ACASI; and administering a five-item measure of social
desirability bias [54].
Potential covariates include demographic characteris-
tics; mental health status as measured by the 45-item
Brief Symptom Inventory (BSI); history of sexual abuse
as measured by the Wyatt Sex History Questionnaire
(WSHQ) [55]; and history of physical abuse as measured
by the 19-item Revised Conflict Tactics Scale (CTS) [56],
which assesses both history and recent (i.e. past 90 days)
experiences of abuse. Hypothesized mediators [57] in-
clude condom use self-efficacy, which has been linked to
effective condom use [58,59], as measured by the Con-
dom Use Self-Efficacy Scale [60]; condom communica-
tion self-efficacy as measured by a nine-item scale
measuring confidence in negotiating the use of a male
condom [60]; and couples’ sexual communication skills
as measured by a seven-item scale on the level of re-
ported comfort on safer sex communication items [61].
Moderators include several variables identified in Eban I
as likely to moderate intervention effects [57]: the length
of the couple’s relationship, because those in longer
relationships are less likely to practice safer sex [45]; re-
lationship satisfaction will be assessed with the DyadicAdjustment Scale [62], which asks how partners relate
to each other about family finances, time spent together,
relational factors, and intimacy; substance use/abuse
(frequency and amount of alcohol use each day in the
past three months and age of first use) as measured by
the CAGE [63] to assess dependence on alcohol, and
section B of the NIDA Risk Behavior Assessment (RBA)
[64] to assess the frequency, modality, and level of use of
licit and illicit drugs in the past month.
Data management and analysis procedures
Quality control procedures
Quality control procedures include quality controls dur-
ing the training of the co-facilitator teams; and during
the running of groups, including checks of a random
sample of audiotaped sessions and providing supervision
and corrective feedback as needed. Co-facilitator teams
will be asked to complete process notes at the end of
each session, and couples will complete satisfaction rat-
ings at the end of each session. Co-facilitator teams, site
coordinators, and couples will also be asked to provide
an overall evaluation of perceived effectiveness and their
level of overall satisfaction with the intervention at the
posttest assessment session.
Sample size calculation and power analyses
Sample size calculation and power analyses were con-
ducted at both the agency- and couple-levels to ensure
that we have sufficient statistical power for all analyses.
At the agency level, the power analysis was based on the
comparisons of key measures from providers (e.g., pro-
vider attitudes toward evidence-based practices). From
the 10 selected agencies, we will collect data from 100
non-clerical staff (10 providers per agency) in order to
provide sufficient power to examine the within- and
between-agency variation. With a type I of 0.05, type II
error of 0.2 (or power of 80%), intra-agency correlation
at 0.15 level, 100 raters from the 10 agencies will enable
us to detect an effect size as small as 0.9 in standard
deviation unit for measures from staff [65,66]. Non-
parametric and parsimonious models will be used to ac-
commodate the limitation of a relatively small number
of agencies.
At the couples level, calculations were carried out
based on the comparison of key outcome measures of
incidents of unprotected sex and an increase in the pro-
portion of condom use (i.e., the number of times con-
doms were used during intercourse divided by the
number of times sexual intercourse is reported) between
intervention and waitlist control. With a repeated mea-
sures design, type I error 0.05, type II error 0.20, intra-
couple correlation 0.4, the mean number of available
repeated measures 2.5 (from baseline, post and three-
month measurements), and a 2:1 ratio of intervention
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us to detect an effect size as small as 0.30 in standard
deviation unit for number of unprotected sexual inter-
course acts [65,67]. Thus, our planned sample of 180
couples provides sufficient power.
Data analysis plan
Specific aim one
Qualitative data will document how we assist the 10
CBOs to implement and sustain the intervention. As a
broad implementation aim, there are no hypotheses as-
sociated with this aim. Instead, the focus will be on de-
scribing the process of assisting the CBOs with
implementation and sustainability. This description and
summary will be generated from interviews and notes
from the monthly SCIN calls, along with other qualita-
tive data that is gathered throughout the study.
Specific aim two
To document the implementation process and identify
barriers and facilitators to adoption, fidelity, and sustain-
ability, we will utilize a variety of analytic approaches.
First, marginal distributions of each of the measures at the
agency level (e.g., intervention cohorts completed, pro-
vider attitudes, etc.) will be obtained. For continuous mea-
sures (e.g., the number of facilitator teams trained), we will
calculate the range, mean, median, quartiles, and standard
deviations. For categorical measures (e.g., fidelity to core
elements), frequency distributions and mode will be ob-
tained. An ordinal measure that reflects the number of
intervention groups conducted at each agency will be cre-
ated, which will be used to link with the number of inter-
vention cycles completed and to test the dose–response of
the intervention. For performance measures (e.g., satisfac-
tion) obtained from providers at the CBOs, analyses will
be conducted, and within and between agency variations
will be examined. Non-parametric methods (e.g., Mann
Whitney test) will be used to accommodate the relative
small sample size of agencies. Rigorous statistical tests will
be conducted in three steps: marginal distributions of the
number of intervention cycles completed will be obtained;
two-way table chi-squares or analysis of variance will be
used to evaluate the relationships between the categories
of number of intervention cycles completed and the ex-
tent of successful implementation, which is measured by
an array of variables (e.g., number of couples served, de-
gree of fidelity, level of satisfaction with the intervention,
etc.); and multivariate analyses will be conducted through
regression models to examine the relationships between
provider measures and number of intervention cycles
completed, controlling for other agency characteristics
such as agency size, number of staff, size of budget, etc.
Data regarding acceptability, barriers, and facilitators
will be derived from interviews and implementation-focused evaluation measures. As we are examining im-
plementation in 10 large, diverse CBOs, barriers and
facilitators will likely vary by agency. The qualitative data
will provide the research team with extensive informa-
tion about acceptability, barriers, and facilitators. In
addition, we will examine the facilitator and couples’ sat-
isfaction ratings to characterize acceptability of the inter-
vention. These ratings will be compared both within and
across agencies. Potential determinants of adoption and
fidelity include but are not limited to training factors,
competency at delivering the intervention, types of facili-
tators (e.g., whether agencies used their own staff as fa-
cilitators or used the floating facilitator team), couple
‘mix’ in a given cohort, retention, and satisfaction. All of
these factors will be examined when characterizing fidel-
ity across agencies. In addition, based on interviews with
facilitators and clients, we will remain open to other de-
terminants that may emerge during implementation.
There are several possible determinants of sustainability.
We hypothesize that sustainability will be achieved in
agencies that have their own trained staff facilitators
who deliver the intervention with fidelity and who had
positive experiences with the intervention during the im-
plementation phase. To test this hypothesis, we will per-
form analyses in two levels: (1) Bivariate analyses
between sustainability and characteristics of the CBOs
and staff. The Pearson Chi-square will be used to test as-
sociation. ANOVA will be used to test the means of the
continuous measures (e.g., ‘the number of agencies that
continue to implement Eban II with fidelity’) across the
different levels of a categorical measure (‘Does your
agency have specific services for high-risk or HIV-
positive couples? Yes/no’) at each time point of data col-
lection; (2) Longitudinal analyses for long-term effects.
Generalized linear mixed models (GLMM) [67,68] will
be used to evaluate the relationship between sustainabil-
ity and characteristics of the CBOs. GLMM cannot only
model global fixed effects (e.g., the number of full-time
staff ), but also can model random variation (e.g., change
over time of individual agency), which is particularly
useful.
Qualitative data analysis—aims one and two
All interviews will be digitally recorded and tran-
scribed by trained staff. ATLAS.ti will be used for
qualitative analysis. Using the constant comparison
analytic approach [69], a preliminary codebook will be
developed both inductively and deductively from a
sub-sample of interviews within and across agencies at
baseline. Qualitative findings at baseline will be aug-
mented by preliminary analyses of staff-level data from
the structured measures described above (e.g., burnout,
attitudes toward evidence-based practices, etc.), and a
baseline profile will be developed for each agency. These
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This approach of using baseline data as diagnostic and in-
formative for tailored implementation has been employed
by the lead author (AH) in a prior implementation study
[29]. The codebook will be elaborated upon and ad-
justed as each round of interviews is reviewed until the-
matic saturation is achieved within and across cycles of
interviews. Interviews will be compared within each
agency, across agencies, across different types of respon-
dents, and over time. Additional sources of qualitative
data (i.e. meeting minutes, archival information) will
also be included in the data set. We will analyze the data
specifically for barriers to and facilitators of implemen-
tation, including but not limited to the ways in which
the project’s strategies and tools affect adoption, fidelity,
and sustainability. In addition to identifying themes and
patterns qualitatively, we will examine statistical associ-
ations between important process and outcome vari-
ables such as satisfaction with the intervention, fidelity,
and retention, and improvement in behavioral out-
comes. Agency profiles will be revisited and further de-
veloped at the end of the active implementation phase,
and again after sustainability.
Specific aim three
We will use repeated measures regression models and
multi-level hierarchical modeling [70,71] to evaluate the
effect of characteristics of agencies, staff, and couples on
the behavioral and psychosocial outcomes. For repeated
measures regression models, we will directly incorporate
measures into models and deal with intra-class correla-
tions from agency and staff through covariance matrix.
With the multi-level nested structure from individuals,
couples, agencies, and staff, the hierarchical models will
be fitted in three possible steps: (a) to set the foundation
for a class of hierarchical models, first we will construct
individual-couple-level models with repeated measure-
ments (baseline, post and three-month) within a couple
that involves time (and intercept); (b) we will then con-
struct across the couples-level models that involve
explanatory variables such as couple demographics;
health history; history of alcohol and recreational drug
use; HIV/AIDS risk reduction knowledge; perceived
couple sexual norms; intervention components, and a
binary variable indicating immediate active treatment or
wait list control; (c) we will model the regression coeffi-
cients obtained from step b at the agency level as func-
tions of explanatory variables of agency characteristics
(e.g., organization size and budget, number of staff, etc.).
Finally, we will then combine models from steps a, b,
and c to form the complete model, which will be estimated
through special procedures and software, such as Win-
BUGS and MlwiN [72,73].Secondary aim
To determine the cost-effectiveness of implementation
of Eban II, standard cost-effective analysis will be con-
ducted using health economic analysis approaches. Two-
staged models (instrumental variable regression) [74,75]
will be applied and implementation costs and potential
costs saving through the intervention will be estimated.
Trial status
Data collection is underway. Data cleaning and analysis
have not commenced.
Discussion
This hybrid implementation/effectiveness study has the
potential to illuminate the processes and complexities
associated with supporting adoption of an evidence-
based program in resource-limited organizations that
typically serve underserved, economically disadvantaged
individuals. The study’s innovative features include the
dynamic wait-listed design [37], the sustainability period
(not typically included in implementation trials) [35], the
real-world effectiveness conditions under which the
intervention is being tested, and the participatory ap-
proach to implementation [76]. One of the overarching
goals of the study is to ‘dive deep’ into the cultures not
only of the organizations but also of their surrounding
communities, which have been greatly impacted by HIV
and by health disparities in general, especially due to
shrinking state and national budgets designated for HIV
prevention efforts in these communities. In systematic-
ally addressing current community-, organizational-, and
client-level complexities with an innovative and part-
nered design, this study exemplifies the five core values
of implementation science: rigor and relevance, effi-
ciency, collaboration, improved capacity, and cumulative
knowledge [44].
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